| Literature DB >> 35348470 |
Rayanne C Ferreira1, Thiago S Torres2, Maria Das Graças B Ceccato3, Daniel Rb Bezerra2, Brett D Thombs4,5,6,7,8,9, Paula M Luz2, Daphna Harel10,11.
Abstract
BACKGROUND: In theoretical models of health behavior, knowledge about disease transmission and self-protective behaviors are conceptualized as important drivers of behavior change. Several studies conducted in Brazil point to an unfortunate convergence of sexual and gender minority (SGM) populations with low levels of HIV knowledge and younger age, lower education, engagement in higher-risk sexual behavior, and never having tested for HIV. Measures to assess level of HIV knowledge have been previously published, including the 12-item HIV/AIDS Knowledge Assessment (HIV-KA) tool. However, measure length can be a barrier to assessment.Entities:
Keywords: Brazil; HIV; knowledge; preexposure prophylaxis; sexual and gender minorities
Mesh:
Year: 2022 PMID: 35348470 PMCID: PMC9132367 DOI: 10.2196/30676
Source DB: PubMed Journal: JMIR Public Health Surveill ISSN: 2369-2960
Descriptive characteristics of participants included in the cross-sectional study among sexual and gender minorities, September 2020, Brazil.
|
| Value | ||
| Age (years), mean (SD) | 35.1 (9.8) | ||
|
| 33 (28-41) | ||
|
| 18-24 | 322 (12.6) | |
|
| 25-34 | 1069 (41.9) | |
|
| 35-44 | 722 (28.3) | |
|
| 45-54 | 311 (12.2) | |
|
| 55+ | 125 (5.0) | |
|
| |||
|
| Cisgender man | 2507 (98.2) | |
|
| Transgender/nonbinary | 45 (1.8) | |
|
| |||
|
| Gay | 2196 (86.1) | |
|
| Bisexual | 302 (11.8) | |
|
| Hetero/pansexual/other | 54 (2.1) | |
|
| |||
|
| White | 1441 (56.5) | |
|
| Pardo | 745 (29.2) | |
|
| Black | 297 (11.6) | |
|
| Asian | 28 (1.1) | |
|
| Indigenous | 18 (0.7) | |
|
| Not declared | 23 (0.9) | |
|
| |||
|
| Middle school | 100 (3.9) | |
|
| High school | 671 (26.5) | |
|
| College+ | 1765 (69.6) | |
|
| |||
|
| Low (≤ 2 × minimum wage or ≤ 400) | 752 (29.5) | |
|
| Middle (> 2-6 × minimum wage or 401-1200) | 1138 (44.6) | |
|
| High (> 6 × minimum wage or > 1200) | 662 (25.9) | |
|
| |||
|
| South/Southeast | 2121 (83.1) | |
|
| North/Northeast/Central-West | 431 (16.9) | |
|
| |||
|
| Grindr | 1753 (68.7) | |
|
| Hornet | 737 (28.9) | |
|
| Other | 62 (2.4) | |
|
| |||
|
| Never tested | 250 (9.8) | |
|
| Negative | 1510 (59.2) | |
|
| Positive | 792 (31.0) | |
|
| |||
|
| Yes | 472 (60.1) | |
|
| No | 313 (39.9) | |
|
| |||
|
| Never | 1412 (80.2) | |
|
| Current | 226 (12.8) | |
|
| Past | 122 (6.9) | |
|
| |||
|
| Yes | 717 (40.7) | |
|
| No | 1043 (59.3) | |
|
| |||
|
| HIV-KAc | 10.99 (1.46) | |
|
| HIV-KQd | 13.07 (1.85) | |
|
| WHO-KIe | 4.76 (0.58) | |
| Perceived U=Uf slogan as completely accurate, n (%) | 1600 (62.7) | ||
aART: antiretroviral therapy.
bPrEP: preexposure prophylaxis.
cHIV-KA: HIV/AIDS Knowledge Assessment tool.
dHIV-KQ: Brief HIV Knowledge Questionnaire.
eWHO-KI: World Health Organization Knowledge about HIV Prevention Indicator.
fU=U: Undetectable=Untransmittable.
Psychometric properties of the short forms of the HIV/AIDS Knowledge Assessment tool in the cross-sectional study among sexual and gender minorities, September 2020, Brazil.
| Short form | Cronbach alpha | Correlation of summed scores with full form scores (95% CI) | Correlation of factor scores with full form score (95% CI) |
| 3 items | .25 | 0.740 (0.722-0.758) | 0.704 (0.684-0.723) |
| 4 items | .42 | 0.798 (0.784-0.812) | 0.803 (0.788-0.816) |
| 5 items | .52 | 0.856 (0.846-0.866) | 0.883 (0.874-0.891) |
| 6 items | .56 | 0.889 (0.881-0.897) | 0.918 (0.912-0.924) |
| 7 items | .56 | 0.897 (0.889-0.904) | 0.922 (0.916-0.928) |
| 8 items | .59 | 0.919 (0.912-0.924) | 0.941 (0.936-0.945) |
| 9 items | .62 | 0.949 (0.945-0.953) | 0.971 (0.968-0.973) |
| 10 items | .63 | 0.962 (0.959-0.965) | 0.980 (0.978-0.981) |
| 11 items | .65 | 0.980 (0.978-0.981) | 0.995 (0.995-0.996) |
| 12 items | .64 | 1 (1-1) | 1 (1-1) |
Convergent validity and equivalency analysis results for the HIV/AIDS Knowledge Assessment tool in comparison to the Brief HIV Knowledge Questionnaire and the World Health Organization Knowledge about HIV Prevention Indicator in the cross-sectional study among sexual and gender minorities, September 2020, Brazil.
|
|
| Equivalency analysis corrected | |||||
| Short form | Summed scores | Factor scores | Summed scores | Factor scores | |||
|
|
|
| |||||
|
| 3 items | 0.390 (0.357-0.423) | 0.425 (0.392-0.456) | >.99 | >.99 | ||
|
| 4 items | 0.431 (0.399-0.462) | 0.404 (0.371-0.436) | >.99 | >.99 | ||
|
| 5 items | 0.456 (0.425-0.486) | 0.420 (0.388-0.451) | >.99 | >.99 | ||
|
| 6 items | 0.507 (0.478-0.536) | 0.470 (0.439-0.500) | >.99 | .83 | ||
|
| 7 items | 0.511 (0.481-0.539) | 0.474 (0.444-0.504) | .93 | .53 | ||
|
| 8 items | 0.526 (0.498-0.554) | 0.496 (0.466-0.525) | .02 | <.001 | ||
|
| 9 items | 0.525 (0.496-0.553) | 0.486 (0.455-0.515) | .01 | <.001 | ||
|
| 10 items | 0.536 (0.508-0.564) | 0.495 (0.465-0.524) | <.001 | <.001 | ||
|
| 11 items | 0.566 (0.539-0.592) | 0.520 (0.491-0.548) | <.001 | <.001 | ||
|
| 12 items | 0.561 (0.534-0.587) | 0.521 (0.492-0.548) | <.001 | <.001 | ||
|
|
|
| |||||
|
| 3 items | 0.396 (0.363-0.428) | 0.418 (0.385-0.449) | >.99 | >.99 | ||
|
| 4 items | 0.430 (0.398-0.461) | 0.395 (0.362-0.428) | >.99 | >.99 | ||
|
| 5 items | 0.416 (0.383-0.447) | 0.369 (0.335-0.402) | >.99 | >.99 | ||
|
| 6 items | 0.457 (0.426-0.487) | 0.415 (0.383-0.447) | >.99 | >.99 | ||
|
| 7 items | 0.472 (0.441-0.502) | 0.426 (0.393-0.457) | >.99 | >.99 | ||
|
| 8 items | 0.566 (0.539-0.591) | 0.508 (0.478-0.536) | <.001 | <.001 | ||
|
| 9 items | 0.538 (0.510-0.565) | 0.476 (0.445-0.505) | .46 | <.001 | ||
|
| 10 items | 0.549 (0.521-0.575) | 0.483 (0.453-0.512) | .002 | <.001 | ||
|
| 11 items | 0.561 (0.533-0.587) | 0.496 (0.466-0.525) | .001 | <.001 | ||
|
| 12 items | 0.584 (0.558-0.609) | 0.509 (0.480-0.537) | .001 | <.001 | ||
aHIV-KQ: Brief HIV Knowledge Questionnaire.
bWHO-KI: World Health Organization Knowledge about HIV Prevention Indicator.
Post hoc convergent and construct validities of the short forms of the HIV/AIDS Knowledge Assessment tool scales according to study variables in the cross-sectional study among sexual and gender minorities, September 2020, Brazil.
|
| 9-item mean (95% CI) | 10-item mean (95% CI) | ||||
|
| ||||||
|
|
| |||||
|
|
| Yes | 8.49 (8.44-8.54) | 9.46 (9.41-9.51) | ||
|
|
| No | 7.86 (7.77-7.96) | 8.83 (8.73-8.92) | ||
|
| ||||||
|
|
| |||||
|
|
| 18-24 | 7.80 (7.63-7.97) | 8.73 (8.54-8.91) | ||
|
|
| 25-34 | 8.30 (8.23-8.37) | 9.26 (9.19-9.34) | ||
|
|
| 35-44 | 8.30 (8.22-8.39) | 9.28 (9.20-9.37) | ||
|
|
| 45-54 | 8.20 (8.07-8.33) | 9.17 (9.04-9.31) | ||
|
|
| 55+ | 7.94 (7.72-8.16) | 8.92 (8.70-9.15) | ||
|
|
| |||||
|
|
| White or Asian | 8.30 (8.24-8.35) | 9.27 (9.21-9.33) | ||
|
|
| Black, Pardo, or indigenous | 8.08 (8.00-8.16) | 9.03 (8.95-9.12) | ||
|
|
| |||||
|
|
| Middle school | 7.16 (6.76-7.56) | 8.02 (7.59-8.45) | ||
|
|
| High school | 7.89 (7.79-7.99) | 8.85 (8.74-8.95) | ||
|
|
| College+ | 8.40 (8.35-8.45) | 9.38 (9.33-9.43) | ||
|
|
| |||||
|
|
| Low | 7.85 (7.74-7.96) | 8.79 (8.68-8.91) | ||
|
|
| Middle | 8.31 (8.25-8.38) | 9.28 (9.22-9.35) | ||
|
|
| High | 8.43 (8.36-8.50) | 9.41 (9.34-9.48) | ||
|
|
| |||||
|
|
| Never tested | 7.29 (7.07-7.52) | 8.20 (7.96-8.44) | ||
|
|
| Negative | 8.19 (8.13-8.25) | 9.16 (9.10-9.23) | ||
|
|
| Positive | 8.53 (8.46-8.59) | 9.49 (9.43-9.56) | ||
|
|
| |||||
|
|
| Never | 7.98 (7.91-8.06) | 8.94 (8.87-9.02) | ||
|
|
| Current | 8.49 (8.38-8.60) | 9.47 (9.36-9.58) | ||
|
|
| Past | 8.20 (7.95-8.46) | 9.16 (8.89-9.44) | ||
|
|
| |||||
|
|
| Yes | 8.09 (7.99-8.19) | 9.05 (8.95-9.16) | ||
|
|
| No | 8.05 (7.96-8.13) | 9.01 (8.93-9.09) | ||
|
|
| |||||
|
|
| Yes | 8.58 (8.50-8.65) | 9.54 (9.46-9.62) | ||
|
|
| No | 8.47 (8.36-8.57) | 9.44 (9.34-9.55) | ||
aU=U: Undetectable=Untransmittable.
bPrEP: preexposure prophylaxis.
cART: antiretroviral therapy.